What Shariah screening methodology does HalalStockGuide use?

We apply all 5 major Shariah screening standards: AAOIFI Standard 21, Dow Jones Islamic Market Index (DJIM), MSCI Islamic, S&P Shariah, and FTSE Shariah. Each standard has different thresholds for debt, cash, receivables, and impermissible income ratios.

Is SAB Biotherapeutics, Inc. (SABSW) Halal?

Q: Is SAB Biotherapeutics, Inc. (SABSW) halal to invest in?

SAB Biotherapeutics, Inc. is Not Halal under AAOIFI Standard 21. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

Q: What are SAB Biotherapeutics, Inc.'s key financial metrics?

SAB Biotherapeutics, Inc. has no P/E data available. Market cap: N/A.

NASDAQ United States N/A

? INSUFFICIENT DATA

Confidence: 0/100

SAB Biotherapeutics, Inc. (SABSW) has insufficient data for a complete Shariah compliance screening. This may be due to missing financial statements or incomplete market data.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard	Debt Ratio	Cash Ratio	Receivables	Income	Status
AAOIFI	N/A	N/A	N/A	N/A	? INSUFFICIENT DATA
DJIM	N/A	N/A	N/A	N/A	? INSUFFICIENT DATA
MSCI	10.6% / 33%	47.0% / 33%	0.1% / 33%	N/A	✗ NOT HALAL
S&P	N/A	N/A	N/A	N/A	? INSUFFICIENT DATA
FTSE	10.6% / 33%	47.0% / 33%	0.1% / 50%	N/A	✗ NOT HALAL

Financial Highlights

Revenue

Cash Flow & Balance Sheet

Total Debt	$5M
Total Assets	$44M

About SAB Biotherapeutics, Inc. (SABSW)

Country

United States

Exchange

NASDAQ

Currency

USD

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Related Halal Stocks in

Frequently Asked Questions

Is SAB Biotherapeutics, Inc. (SABSW) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), SAB Biotherapeutics, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is SAB Biotherapeutics, Inc.'s debt ratio?

SAB Biotherapeutics, Inc.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 10.6%.

What are SAB Biotherapeutics, Inc.'s key financial metrics?

SAB Biotherapeutics, Inc. has a market capitalization of N/A.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.